Author: Ken Dropiewski

BIOTRONIK Enrolls First Patient Into BIO-CONDUCT, First IDE Trial to Study Use of Stylet-Driven Leads for Conduction System Pacing

LAKE OSWEGO, Ore., Dec. 12, 2022 /PRNewswire/ — BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA approved investigational device exemption (IDE) trial examining the use of the BIOTRONIK Solia S pacing lead when implanted in the […]

Efemoral Medical Announces Series A1 Funding

New funding will support increasing enrollment in its ongoing first-in-human trial, EFEMORAL I LOS ALTOS, Calif., Dec. 13, 2022 /PRNewswire/ — Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced the closing of its $4.9M preferred Series A1 round. Supported by existing investors as well as an experienced cohort of new investors, the proceeds […]

Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation And 3D Mapping & Navigation For Treatment of Cardiac Arrhythmias

CARDIFF-BY-THE-SEA, Calif. and BOULDER, Colo., Dec. 13, 2022 /PRNewswire/ — Today, Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of-its-kind, purpose built, focal pulsed field ablation (PFA) therapy integrated seamlessly with 3D mapping & navigation. Both teams will harness decades of experience in pioneering novel PFA and navigation product […]

Renibus Therapeutics Strengthens Leadership Team with Asha Ramdas as SVP, Program Management, Technical Operations and Manufacturing

-Ms. Ramdas has more than 25 years of healthcare experience, including at Amgen and Johnson & Johnson- SOUTHLAKE, Texas, Dec. 13, 2022 /PRNewswire/ — Renibus Therapeutics, Inc., (“Renibus”), a clinical-stage biotechnology company developing breakthrough products for cardiorenal diseases, today announced the appointment of Asha Ramdas as SVP, Program Management, Technical Operations and Manufacturing. Ms. […]

Nuwellis Announces Data Supporting Lower Heart Failure Hospitalizations and Readmissions With Aquadex

The peer-reviewed publication shows 81% lower heart failure hospitalizations per year and a 48% decrease in rehospitalizations from the national average at 30 days MINNEAPOLIS, Dec. 13, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today […]

A New Study From Hello Heart Shows Surprising Findings on Walking Patterns and Heart Health

Correlations between lifestyle changes and blood pressure indicate how a person could increase their walking to positively impact heart health MENLO PARK, Calif.–(BUSINESS WIRE)–Hello Heart, the only digital therapeutic that focuses exclusively on heart health, today announced new data on how minor lifestyle and behavioral changes can have a significant […]

Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited

MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited (“Acotec” and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions […]

Riverside Medical Center Performs First In-Patient Use of Biomaterial-Based HydroPICC® Dual Lumen Catheter

Biomaterial catheters help avoid common vascular access complications, delivering improved patient outcomes and a lower cost of care BILLERICA, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI) today announced that Riverside Medical Center, located just outside the Chicago area, was the first in the nation to use its […]